IMCC - Im Cannabis Corp

IMCC - Im Cannabis Corp

https://imcannabis.com

Momentum: Bearish

Recent News

Powered by Alpha Vantage

IM Cannabis: 66% Revenue Growth In Germany, Narrows EBITDA Loss In Q3 - IM Cannabis ( NASDAQ:IMCC )

Benzinga • 10 months ago • score: 0.14

International medical cannabis company IM Cannabis Corp. IMCC IMCC announced its financial results on Thursday for the third quarter ended Sept. 30, 2024. The company reported revenue from Germany grew 66% year-over-year, reaching CA$5.8 million ( $4.1 million ) .

IM Cannabis' $1.6M Non-Brokered Private Placement Offering, Here's What Investors Need To Know - IM Cannabis ( NASDAQ:IMCC )

Benzinga • 11 months, 1 week ago

Medical cannabis company with operations in Israel and Germany, IM Cannabis Corp. IMCC IMCC, intends to undertake a non-brokered private placement offering of up to $1,613,000 through the sale of roughly 625,000 units.

How Cannabis Legalization In Germany Boosted This Company's Revenue, Will Spain's Medical Marijuana Framework Do The Same? - IM Cannabis ( NASDAQ:IMCC )

Benzinga • 11 months, 1 week ago • score: 0.19

Spain's Ministry of Health revealed this week a draft royal decree for public consultation, outlining the suggested regulations for prescribing cannabis-based medications, reported Business of Cannabis. The news comes after years of negotiation and an increase in the legal production of medical ...

IM Cannabis Corp. ( IMCC ) Reports Q2 Loss, Tops Revenue Estimates

Zacks Commentary • 1 year, 1 month ago • score: 0.13

IM Cannabis (IMCC) delivered earnings and revenue surprises of 79.76% and 12.07%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

IM Cannabis Corp. The company is headquartered in Tel Aviv-Yafo, Israel.

52W High

$7.12

52W Low

$1.29

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

2.15

Valuation

Fair

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

16.31

EV/EBITDA (<8 favorable)

7.36

EV/Revenue (<3 favorable)

0.56

P/S (TTM) (<3 favorable)

0.20

P/B (<3 favorable)

4.05

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

44.66%

Institutions (25–75% balanced)

4.31%

Shares Outstanding

5,246,800

Float

2,405,900

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

52,414,000

Gross Profit (TTM)

12,701,000

EPS (TTM)

-0.49

Profit Margin (>10% good)

-0.04%

Operating Margin (TTM) (higher better)

-0.03%

ROE (TTM) (>15% strong)

-0.49%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

-0.14

Momentum

Bearish momentum

Value

-0.2196

Previous

-0.2285

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025